跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MINT-SOLIFENACIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MINT-SOLIFENACIN
Authorized
STANDARD
MINT-SOLIFENACIN
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
46c71a1ef6274415
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
46c71a1ef6274415
Drug Approval Canada Name
MINT-SOLIFENACIN
Product Name
MINT-SOLIFENACIN
Status
Cancelled Post Market
Status Date
2019-11-20
Original Market Date
2016-04-20
Din
02443171
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
86:12.04
Atc Original
G04BD08 SOLIFENACIN
Atc Name
g 04 bd 08
Aig Number
0151584001
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
SOLIFENACIN SUCCINATE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
46c71a1ef6274415
Type
Standard
Back to Health Canada Approvals